In a four - year study conducted on the mouse model in advanced
breast cancer metastasis in the eye's anterior chamber, Petty and colleagues found that the new nanoparticle not only killed tumor
cells in the eye, but also extended the survival of experimental mice
bearing 4T1 tumors, a
cell line that is extremely difficult to kill.